We have generated two zebrafish lines carrying inactivating germline mutations in the von 
Introduction
The von Hippel-Lindau tumor suppressor (VHL) plays a critical role in the adaptive cellular response to hypoxia through the negative regulation of hypoxia-inducible factors (HIFs). VHL protein (pVHL) is the substrate recognition component of the multisubunit VHL-E3 ubiquitin ligase complex. The interaction between pVHL and HIF alpha subunits (HIF-1-3α) requires oxygen-dependent hydroxylation of HIF-α on either of two prolyl residues by the family of prolyl hydroxylases (PHD1-3). Upon binding pVHL, HIF-α is targeted for proteasomal degradation by polyubiquitination. In the absence of oxygen or functional pVHL, HIF-α is stabilized and translocated to the nucleus where it partners with HIF-β to mediate transcription of hypoxia-inducible genes to facilitate glucose uptake, glycolysis and oxygen delivery by increasing angiogenesis and erythropoiesis (for review see Kaelin 1 ).
Congenital erythrocytoses or polycythemias are rare autosomal recessive disorders often found to be associated with homozygous or compound heterozygous germline mutations in VHL (for review see Gordeuk et al. 2 ). The most frequently found mutation in VHL-related erythrocytosis is the C598T transition 3 , inducing the Chuvash form of polycythemia (CP). The resulting Arg200Trp (R200W) substitution at the extreme C-terminus of pVHL diminishes the binding affinity for hydroxylated HIF-α, thereby partially inhibiting its normoxic ubiquitination and degradation that results in the pathological upregulation of HIF target genes including: glucose transporter member 1 (GLUT1), vascular endothelial growth factor (VEGF) and erythropoietin (EPO) 3 . Chuvash polycythemia is further characterized by high hemoglobin and hematocrit levels. Patients have abnormalities in respiratory and pulmonary vascular regulation. Basal ventilation and pulmonary vascular tone are elevated, and ventilatory, pulmonary vasoconstrictive and heart rate responses to acute hypoxia are greatly increased 4 . Premature mortality is observed as a result of cerebral vascular events or peripheral thrombosis 5 .
CP is distinct from the hereditary cancer syndrome known as VHL disease, that is associated with heterozygous fully inactivating germline mutations in VHL 1 . Inactivation of the remaining allele in somatic cells predisposes VHL patients to the development of highly vascularized tumors and cysts in many organ systems, including hemangioblastomas of the retina and central nervous system, pheochromocytomas and clear-cell renal cell carcinoma (ccRCC) 1, 6 . Patients with VHL disease can develop secondary polycythemias in response to EPO production from
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To study VHL function in vivo and to gain insight into these two distinct disease etiologies, several murine models have been generated (for review see Haase 8 ). Vhlh knock-out mice obtained by conventional homologous recombination die in utero between E10.5-12.5 due to hemorrhagic lesions in the placenta 8 . To avoid embryonic lethality, Cre/lox site-specific recombination technology was employed and multiple tissue or organ specific Vhlh deletions were engineered. While several VHL disease aspects were observed, conditional knock-out mice do not develop human VHL disease-associated tumors or ccRCC. Deletion of Vhlh in the liver and kidney results in secondary polycythemias as a cause of increased Epo production in the liver 8 . Mice homozygous for the CP R200W mutation were recently shown to develop polycythemia from 10-14 weeks after birth similar to the human disease, however cardiopulmonary defects were not described 9 .
While these murine models have contributed greatly to our understanding of VHL function, their use is limited since they lack important aspects of VHL-associated pathologies. To explore the underlying mechanisms of CP and VHL disease an additional animal model is warranted.
Zebrafish have become a valuable model system for vertebrate biology, human disease and cancer 10 . Importantly, the HIF pathway 11, 12 is highly conserved, as are other vertebrate genetic programs such as hematopoiesis 13, 14 and EPO 15 signaling.
Here, we report the identification and first characterization of the zebrafish VHL ortholog vhl.
Using target-selected gene inactivation 16 
In situ hybridization
A full-length vhl construct and anti-sense digoxygenin (Roche, https://www.roche-appliedscience.com/) labeled mRNA probe were generated as described in Data Supplement 1. Other anti-sense mRNA probes used were either transcribed from EST clones (RZPD/Imagenes, http://www.imagenes-bio.de/ ): phd3 (BC066699), ldha1 (BC067188), ndufa4 (BC059706), epo (CK239342), epor (NM_001043334), glut1 (BI706432), lck (NM_001001596); or as previously described: vegfa 21 , scl 22 , gata1 21 , ikaros 23 , l-plastin 24 , mpo 25 , c-myb 26 , betaE1 globin 27 , kdr-like 28 and kdr 28 . Whole-mount in situ hybridizations were performed as described in Data supplement 1. Embryos were imaged in 2% methylcellulose on a depression slide and imaged on a Zeiss (http://www.zeiss.com/) axioplan microscope with a 5x objective.
Agilent Microarray expression profile
Total RNA from 40 vhl mutants and 40 siblings (equally pooled from four different clutches) at 7 dpf was isolated using TRIzol (Invitrogen, http://www.invitrogen.com/). A 4x44K zebrafish expression array (G2519F, Agilent Technologies, http://www.home.agilent.com/) was performed according to the manufacturers protocol (Data Supplement 1). Scanned images were processed using the Feature Extraction software (Agilent Technologies), and analyzed (P-value ≤ 0.01) using Limma in R software 29 . These data have been deposited in NCBI's Gene Expression 
Hematopoietic analyses
For blood smears, o-dianisidine and May-Grünwald Giemsa staining procedures, and ironinjections see Data supplement 1. Blood cell images were collected on a Zeiss Axioskop 2 with a 40x objective, using a Leica DFC490 digital camera. CD41-GFP+ hematopoietic cells were imaged on a Leica DM IRE2 confocal microscope using a 40x oil objective.
Determining heart rate, stroke volume and cardiac output
Heart rate, stroke volume and cardiac output were determined by high speed videomicroscopy, as previously described 31 (Data supplement 1).
Generation of full-length human VHLp30 and VHL R200W rescue constructs
VHLp30 (reference Lolkema et al.
32
) and VHL R200W rescue constructs and mRNA were generated as described in Data Supplement 1. For mRNA injections, 7.5 pg VHLp30 or VHL R200W mRNA was injected into the yolk of 1-cell stage embryos and translation of the mRNAs was verified by western blot analysis. Following phenotypic analysis embryos were genotyped. When the mouth is fully developed by 4-5 dpf, vhl -/-embryos begin to hyperventilate, displaying up to 80 buccal movements per minute versus 1 per minute in siblings at 8 dpf (Supplemental movie 1). Similar to CP patients, time course analysis of the heart rate and cardiac output revealed an increased cardio-physiological response in vhl mutants ( Figure 2a ). From 7 dpf the vhl -/-heart rate was significantly elevated (Figure 2a ) and the stroke volume was increased (not shown). This resulted in a significantly elevated cardiac output (heart rate x stroke volume) from a 3.2 fold increase at 4 dpf (139±7.6 vs. 43.5±4.1 nl/min) to a 15 fold increase (137.3±17.5 vs.
9.4±1.5 nl/min) in 10 day old vhl mutants. While overall cardiac output in mutants did not significantly alter from 4-10 dpf (around 152±10.6 nl/min), siblings showed a significant reduction from 43.5 to 9.4 nl/min, according to normal developmental trends as described previously 35 . In response to the increased cardiac output, vhl mutants developed progressive cardiac dilation that is characterized by cardiomegaly and stretched cardiomyocytes at 8 dpf (Figure 2b,c) . Vhl -/-larvae survive up to 8-11 days, when more frequent arrhythmias and atrial shape defects were observed, suggesting the onset of congestive heart failure. Vhl mutants ultimately develop severe edema and die. Furthermore, mRNA levels of epo (liver and glomerulus) and its receptor epor (heart, pronephric hematopoietic tissue) are elevated in vhl mutants as shown at 7.5 dpf (Figure 2g ). Epo signaling is mediated via the JAK/STAT signaling pathway. Upon binding of Epo to its receptor EpoR, Jak2a is recruited, leading to the phosphorylation and activation of transcription factor STAT5.
Since dysregulated JAK/STAT signaling is a key feature of polycythemia in patients, we performed western analysis of STAT5/phosphoSTAT5 levels to investigate whether elevated epo/epor mRNA levels would lead to increased Epo-signaling in vhl mutants. Already at 2 dpf,
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Our results indicate that vhl mutants display an increased c-myb + hematopoietic stem cell population in the CHT when compared to age-matched siblings.
Enhanced proliferation of the hematopoietic compartments
To determine whether vhl -/--induced polycythemia is attributable to increased hematopoietic proliferation, BrdU incorporation assays were performed. While in siblings a general low proliferation rate was observed at 7.5 dpf, vhl mutants displayed specific hyperproliferation in 36 ), CHT and sub-aortic hematopoietic patches could be clearly discerned ( Figure   3f ).
Upregulation of red and white hematopoietic lineages
In situ hybridizations revealed a global upregulation of both red and white hematopoietic lineages as shown at 7.5 dpf (Figure 4 ). 
Increased number of circulating erythroid progenitors
We interrogated whether blood composition was altered by May-Grünwald Giemsa stained blood smears at 8 dpf. By analyzing approximately 100 blood cells per embryo, we observed a marked increase in circulating orthochromatophilic erythroblasts in vhl mutants (40%, n=9) compared to siblings (5%, n=9), indicating an increased number of erythroid precursors ( Figure   5a ). Furthermore, the cytoplasm of the morphologically more mature vhl -/-erythrocytes appeared paler or hypochromic. To assess whether this could be attributed to anemia (iron deficiency), blood cells were stained with o-dianisidine, which reacts with iron in heme. Whereas erythrocytes uniformly stained dark brown in siblings, variable heme levels were detected in vhl -/-erythrocytes at 6.5 dpf (Figure 5bi , iii) and 8 dpf (Figure 2c , visible in the accumulated blood in the heart). Injection of 100 mM iron-dextran at 2 dpf rescued the observed anemic phenotype (Figure 5biiii ). Rescue could even be observed in live vhl mutants by darker red circulating blood cells (Figure 5c ). Since zebrafish embryos in this study were not fed and thus iron stores are limited, the observed late anemia is likely secondary to the constant over-production of red blood 4 .
Human VHLp30 mRNA rescues vhl -/-polycythemia
To confirm the described polycythemic phenotype to reflect loss of vhl we injected vhl mutants with 7.5 pg mRNA of either the full-length human VHLp30 or the CP VHL R200W allele at the 1-cell stage (Figure 6a,b) , and verified translation by western analysis (Figure 6c) 
Chemically induced Hif signaling in wild type embryos by DMOG partly mimics the vhl hypoxic phenotype
Collectively, our data support the notion that vhl mutants experience a prolonged systemic artificial hypoxic response under normoxic conditions, and that Hif-targets such as Epo play a key role in the observed hematopoietic phenotype. While our data suggests stabilization of Hif, evidence remains indirect because no antibodies against zebrafish Hif-α subunits are available.
We therefore took a chemical approach to activate Hif signaling in wild-type embryos with the non-specific PHD/FIH-inhibitor dimethyloxalylglycine (DMOG) to compare the resulting (molecular) phenotype to age-matched vhl mutants. In embryos younger than 2 dpf treatment with 10-100μM DMOG was lethal or severely toxic (not shown). Three day old embryos treated with 100μM DMOG for 4 days develop normally and display a strong hypoxic response. Like vhl mutants, at 7 dpf DMOG treated embryos hyperventilate (not shown), and have an increased However, inter-species differences cannot be excluded.
Similar to CP patients and unique to our zebrafish model, vhl mutants have striking abnormalities in heart and basal ventilation rates, characteristic of acclimatization to hypoxia at high altitude. Induced hypoxia in zebrafish has been shown to increase heart rate from 4-12 dpf at P O2 ≤ 10 kPa 31, 44 , however, enlargement of the heart was not described. Recently, it was reported that specific deletion of Vhlh in mouse cardiomyocytes results in HIF-1α-dependent cardiac dilation, increased cardiac weight, and heart failure from 5 months of age 45 . Malignant cardiac transformations were frequently found that have not been observed in human VHL patients. Since cardiophysiological parameters were not altered, this study shows that chronic cardiac activation of HIF-α alone does not affect heart rate and cardiac output. Interestingly, adult transgenic mice over-expressing human EPO develop an increased heart size and weight, while blood pressure was not elevated and cardiac output was not decreased (which is normally observed during prolonged hypoxia) 39 . However, other studies using similar transgenic mouse strains did not observe changes in heart size and cardiac output 46 . EPO has been shown to be a key factor in modulating neural respiratory control in hypoxia by acting on both the central epo (liver and glomerulus) and its receptor epor are highly up-regulated in 7.5 dpf vhl mutants.
(h) Western blot analysis of STAT5/phosphoSTAT5 levels at 2 and 4 dpf. At both time points, phosphoSTAT5 levels are highly increased in vhl mutants, while STAT5 levels remain For ----------------------------------------------------- beats/min heart rate 
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